Zydus Lifesciences Ltd share price logo

Zydus Lifesciences Share Price

NSE: ZYDUSLIFE

BSE: 532321

Mid Cap

Healthcare Sector

₹882.00

-3.30

(-0.37%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Regulatory Alert

Zydus Lifesciences' Ankleshwar facility inspection by US FDA concluded with three observations; no data integrity issues reported.

Zydus Lifesciences Stock Performance

as on January 23, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹880.00
    ₹897.15
    downward going graph

    0.23%

    Downside

    1.72%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹795.00
    ₹1,059.05
    downward going graph

    9.86%

    Downside

    20.07%

    Upside

    downward going graph

Zydus Lifesciences share price movements today

Previous Close
₹885.30
Open
₹886.50
Volume
4.60L
Upper Circuit
₹973.80
Lower Circuit
₹796.80
Day's Low - High
₹880.00 - ₹897.15
52 Week Low - High
₹795.00 - ₹1,059.05

Zydus Lifesciences Historical Returns

1 Month Return
-2.5 %
3 Month Return
-13 %
1 Year Return
-4.4 %
3 Year Return
+ 104.97 %
5 Year Return
+ 90.89 %

Zydus Lifesciences Fundamentals

as on January 23, 2026 at 4:01 pm IST

Market Cap

₹88,749.84 Cr

Return on Equity (ROE)

31.29

PE Ratio (TTM)

18.04

Return on capital employed (ROCE)

30.47

Industry PE ratio

40.46

Beta (LTM)

0.93

P/B Ratio

4.2

Dividend Yield

1.24

PEG Ratio

2.89

Quarterly Earnings Growth YOY

37.33

EPS (TTM)

45.87

Sector

Pharmaceuticals

Book Value

238.1

Technical Analysis

Bearish

View Technical Analysis

Zydus Lifesciences Stock Valuation

as on January 23, 2026 at 4:01 pm IST

Zydus Lifesciences in the last 5 years

  • Overview

  • Trends

Lowest (7.34x)

March 7, 2022

Today (18.04x)

January 23, 2026

Industry (40.46x)

January 23, 2026

Highest (34.62x)

March 26, 2024

LowHigh

Today’s Price to Earnings Ratio: 18.04x

Zydus Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD88,749.8418.18%0.614,61423,241
Sanofi India Ltd image
Sanofi India Ltd
BUY9,363.54-9.82%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY65,775.783.6%0.603,48331,723
Abbott India Ltd image
Abbott India Ltd
BUY59,032.5018.25%0.001,4146,445
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY39,190.3911.53%0.569273,749
See all

Analyst Recommendation on Zydus Lifesciences Stock

Based on 30 analysts

HOLD

43.33%

Buy

33.33%

Hold

23.33%

Sell

Based on 30 analysts, 43.33% of analysts recommend a 'HOLD' rating for Zydus Lifesciences. Average target price of ₹1013.57

Source: S&P Global Market Intelligence

Zydus Lifesciences Share Price Target

Get share price movements and forecasts by analysts on Zydus Lifesciences.

What analysts predicted

14.92%UPSIDE

Target Price

₹1013.57

Current Price

₹882

Analyzed by

30 Analysts

High

₹1255

Target

₹1013.57

Low

₹850

Zydus Lifesciences target price ₹1013.57, a slight upside of 14.92% compared to current price of ₹882. According to 30 analysts rating.

Source: S&P Global Market Intelligence

Zydus Lifesciences Stock’s Investor Sentiment and Interest

Investment in Zydus Lifesciences Ltd Shares on INDmoney has dropped by -8.92% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-8.92% versus previous 30 day period

Search interest for Zydus Lifesciences Ltd Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:15% versus previous 30 day period

Zydus Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
4,852.5
5,052.8
4,258.6
4,343.7
5,366.4
6,046.5
5,113.6
5,123.5
6,290.2
6,467
6,037.9
Other Income
37.8
36
54
59.5
159.6
63.2
68.5
57.5
80.6
154.9
109
Total Income
5,048.4
5,175.6
4,422.8
4,564.7
5,693.4
6,270.7
5,305.5
5,326.6
6,608.5
6,728.6
6,232.2
Expenses
4,358.5
3,649.5
3,223.7
3,402.8
3,903.3
4,123.5
3,775.6
3,881.8
4,622
4,485.2
4,141.6
Operating Profit
494
1,403.3
1,034.9
940.9
1,463.1
1,923
1,338
1,241.7
1,668.2
1,981.8
1,896.3
Operating Profit Margin %
10.18%
27.77%
24.3%
21.66%
27.26%
31.8%
26.17%
24.24%
26.52%
30.64%
31.41%
Profit Before Interest, Tax and Depreciation
689.9
1,526.1
1,199.1
1,161.9
1,790.1
2,147.2
1,529.9
1,444.8
1,986.5
2,243.4
2,090.6
Interest
27.7
18.1
8.7
19.8
34.6
32.2
25.1
32
76.6
84.7
101.3
Depreciation
178.6
179.8
184.2
194.8
205.3
215.3
233.6
229
237.9
238.1
301.9
Profit Before Tax
483.6
1,328.2
1,006.2
947.3
1,550.2
1,899.7
1,271.2
1,183.8
1,672
1,920.6
1,687.4
Tax Paid
137.2
216.1
226.4
213.8
321.2
436.1
373.1
179.5
423.2
434
454
Profit After Tax
346.4
1,112.1
779.8
733.5
1,229
1,463.6
898.1
1,004.3
1,248.8
1,486.6
1,233.4
Total Net profit including share of profit / Loss from associate company
358.2
1,133.6
803.2
789.9
1,246.1
1,482.5
920.2
1,026.2
1,243.7
1,521
1,238.6
EPS
2.93
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
Actual EPS
2.93
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
Adjusted EPS
2.93
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
Diluted EPS
2.93
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51

Zydus Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
9,167.3
11,581.3
12,748.4
13,812.1
14,125
14,827.6
16,877.8
19,021.5
22,573.8
Other Income
128.4
113.2
201.1
113.9
45.6
2,583.1
186.6
307.1
269.5
Total Income
9,504.9
12,018.1
13,366.7
14,367
14,449.1
17,693
17,424
19,854.5
23,511
Expenses
7,475.1
9,076.2
10,192.5
11,833.3
11,289.5
11,769.2
13,986.3
14,177.3
16,402.6
Operating Profit
1,692.2
2,505.1
2,555.9
1,978.8
2,835.5
3,058.4
2,891.5
4,844.2
6,171.2
Operating Profit Margin %
18.46%
21.63%
20.05%
14.33%
20.07%
20.63%
17.13%
25.47%
27.34%
Profit Before Interest, Tax and Depreciation
2,029.8
2,941.9
3,174.2
2,533.7
3,159.6
5,923.8
3,437.7
5,677.2
7,108.4
Interest
44.6
91.1
193.5
341.8
158.8
127
129.9
81.2
165.9
Depreciation
373.3
538.8
598.6
696.5
669.6
713
722.7
764.1
915.8
Profit Before Tax
1,611.9
2,312
2,382.1
1,495.4
2,331.2
5,083.8
2,585.1
4,831.9
6,026.7
Tax Paid
128.9
564.4
530.3
319.8
193.6
511.7
587.8
977.5
1,411.9
Profit After Tax
1,483
1,747.6
1,851.8
1,175.6
2,137.6
4,572.1
1,997.3
3,854.4
4,614.8
Total Net profit including share of profit / Loss from associate company
1,516.8
1,810.4
1,898.7
1,204.4
2,185
4,618.3
2,091.9
3,972.8
4,672.6
EPS
14.53
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
Actual EPS
14.53
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
Adjusted EPS
14.53
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
Diluted EPS
14.53
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97

Zydus Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,893.5
1,311.7
919.3
1,281.9
2,931.5
3,293.9
2,104.5
2,688.8
3,196.3
6,776.7
Cash Flow from Investing Activities
-859.6
-2,871.9
-973.7
-3,977.4
-1,004.4
-836.7
-1,017.6
1,541.6
-1,492.3
-8,377.1
Cash Flow from Financing Activities
-934.8
2,315.8
51.5
1,884.6
-1,528.2
-2,547.7
-868.3
-4,400.4
-1,778.8
2,014.2
Net Cash Flow
99.1
755.6
-2.9
-810.9
398.9
-90.5
218.6
-170
-74.8
413.8

Zydus Lifesciences Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.99%
74.99%
74.99%
75%
DII
13.6%
13.23%
13.09%
12.79%
12.63%
12.64%
10.65%
10.65%
11.01%
11.13%
10.86%
11.09%
FII
0%
0%
0%
0%
5.72%
5.59%
7.52%
7.53%
7.32%
7.13%
7.34%
7.06%
Public
8%
7.47%
7.07%
6.99%
6.66%
6.8%
6.85%
6.84%
6.68%
6.74%
6.8%
6.85%
Total Outstanding Shares
1,01,22,04,139
1,01,22,04,139
1,01,22,04,139
1,01,22,04,139
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
Total Shareholders
3,38,570
3,11,764
2,97,953
3,06,495
2,94,324
3,36,309
3,70,863
3,65,356
3,71,619
3,86,127
3,96,105
4,03,266

Mutual Funds that own Zydus Lifesciences Stock

Check out the Mutual Funds with significant holdings in Zydus Lifesciences.

Zydus Lifesciences Corporate Actions

View detailed summary of the earnings and dividend history of Zydus Lifesciences.

  • Zydus Lifesciences Ltd Earnings Results

    Zydus Lifesciences Ltd’s net profit jumped 38.13% since last year same period to ₹1,258.60Cr in the Q2 2025-2026. On a quarterly growth basis, Zydus Lifesciences Ltd has generated -14.19% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Zydus Lifesciences Ltd Dividends May,2025

    In the quarter ending March 2025, Zydus Lifesciences Ltd has declared dividend of ₹11.00 per share on 19 May 2025 - translating a dividend yield of 1.25%.

    Read More about Dividends

Zydus Lifesciences News & Key Events

  • img

    Today's Timeline - 27 January

    08:20 AM

    -

    Zydus Lifesciences reports US FDA inspection at Ankleshwar facility concluded with three observations, no data integrity issues.

Indices Featuring Zydus Lifesciences Stock

Check stock indices that include Zydus Lifesciences.

Nifty Healthcare

₹13,957.30

-0.83 (▲116.70%)

Nifty100 Eq Weig

₹32,539.35

-1.75 (▲578.80%)

BSE Healthcare

₹41,313.49

-1.21 (▲504.50%)

Nifty LargeMidcap 250

₹16,021.80

-1.42 (▲230.50%)

NIFTY PHARMA

₹21,722.25

-0.94 (▲205.75%)

NIFTY 100

₹25,570.50

-1.12 (▲289.75%)

S&P BSE 400 MidSmallCap

₹11,312.59

-1.82 (▲210.29%)

BSE 500

₹35,609.90

-1.33 (▲478.76%)

S&P BSE 150 MidCap

₹15,456.70

-1.72 (▲270.38%)

Nifty100 Quality

₹5,761.65

-0.46 (▲26.80%)

BSE 200

₹11,279.62

-1.25 (▲142.39%)

Nifty Next 50

₹66,260.55

-1.97 (▲1332.25%)

Nifty 200

₹13,889.10

-1.24 (▲174.80%)

S&P BSE Largecap

₹9,608.20

-1.16 (▲112.73%)

S&P BSE Dividend Stability

₹1,039.41

-0.92 (▲9.69%)

S&P BSE 250 LargeMidCap

₹10,686.57

-1.25 (▲135.81%)

Nifty 500

₹22,706.20

-1.31 (▲302.55%)

Insights on Zydus Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.80% to 6.85% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ZYDUSLIFE stock has moved up by 0.1%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.70% to 4.71% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 74.99% to 75.00% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 155.8% return, outperforming this stock by 50.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 17.8% return, outperforming this stock by 22.2%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 7.34% to 7.06% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 6.72K Cr → 6.23K Cr (in ₹), with an average decrease of 7.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.46K Cr → 1.25K Cr (in ₹), with an average decrease of 14.2% per quarter

Zydus Lifesciences Stock Futures & Options Contracts

View the latest movement in Zydus Lifesciences Futures & Options, including strike prices, expiry dates, and percentage changes.

Zydus Lifesciences Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 27 Jan ₹900 Call
January 27, 2026
₹900
₹1.95
-0.55
-22%
ZYDUSLIFE 27 Jan ₹890 Call
January 27, 2026
₹890
₹4.25
-1.15
-21.3%
ZYDUSLIFE 27 Jan ₹910 Call
January 27, 2026
₹910
₹0.75
-0.3
-28.57%
ZYDUSLIFE 24 Feb ₹900 Call
February 24, 2026
₹900
₹22.85
-0.95
-3.99%

Zydus Lifesciences Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 24 Feb Fut
February 24, 2026
-
₹888.75
-1.87
-0.21%
ZYDUSLIFE 27 Jan Fut
January 27, 2026
-
₹884
-2.75
-0.31%
ZYDUSLIFE 30 Mar Fut
March 30, 2026
-
₹892.8
-2.96
-0.33%

About Zydus Lifesciences Ltd

Zydus Lifesciences Ltd is a leading pharmaceutical company headquartered in Ahmedabad, India. Incorporated in 1995, the company operates in a number of lines of business, including active pharmaceutical ingredients, formulations, biotechnology, and nutraceuticals.

The company has a strong presence in the global market and is known for its high-quality pharmaceutical products. It manufactures a wide range of generic and specialty drugs, including cardiovascular, anti-infective, anti-diabetic, and oncology medicines. Zydus also produces over-the-counter products and nutritional supplements. Some of its top products include Zetia, Atorvastatin, and Metformin.

Zydus Lifesciences Ltd is also known for its popular brands, such as Cadila, Nutralite, and Zydus Wellness. The company has a strong presence in the Indian market, with its products being sold in more than 20,000 stores across the country. It also exports its products to over 100 countries worldwide.

Revenue: ₹6,037.90Cr as on September 2025 (Q2 FY26)
Net Profit: ₹1,233.40Cr as on September 2025 (Q2 FY26)
Listing date: 18 Apr, 2000
Chairperson Name: Pankaj R Patel
OrganisationZydus Lifesciences Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOPankaj R Patel
E-voting on sharesClick here to vote

FAQs

What is Zydus Lifesciences share price today?

Zydus Lifesciences share price today stands at ₹882 as on . Zydus Lifesciences share today touched a day high of ₹897.15 and a low of ₹880.

What is the 52 week high and 52 week low range for Zydus Lifesciences share?

Zydus Lifesciences touched a 52 week high of ₹1059.05 and a 52 week low of ₹795. Zydus Lifesciences share price today i.e. is trending at ₹882, which is -16.72% down from its 52 week high and 10.94% up from its 52 week low.

What is Zydus Lifesciences's market capitalisation today?

Zydus Lifesciences market capitalisation is ₹88,749.84 Cr as on .

How to buy Zydus Lifesciences shares?

To buy Zydus Lifesciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ZYDUSLIFE or Zydus Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Zydus Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Zydus Lifesciences trading volume today?

Zydus Lifesciences trading volume is 4.60L as on . This means that 4.60L shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.